A New Signaling Pathway (JAK-Fes-phospholipase D) That Is Enhanced in Highly Proliferative Breast Cancer Cells-Reference-Cited by-同舟云学术

A New Signaling Pathway (JAK-Fes-phospholipase D) That Is Enhanced in Highly Proliferative Breast Cancer Cells

Published:2013-04 Issue:14 Volume:288 Page:9881-9891
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Ye Qing,Kantonen Samuel,Henkels Karen M.,Gomez-Cambronero Julian

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference40 articles.

1. Isolation and partial characterization of surface components of cell line MDA-MB-231 derived from a human metastatic breast carcinoma;Walker-Nasir;J. Natl. Cancer Inst.,1982

2. Human ADP-ribosylation factor-activated phosphatidylcholine-specific phospholipase D defines a new and highly conserved gene family;Hammond;J. Biol. Chem.,1995

3. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization;Colley;Curr. Biol.,1997

4. Understanding phospholipase D (PLD) using leukocytes: PLD involvement in cell adhesion and chemotaxis;Gomez-Cambronero;J. Leukoc. Biol.,2007

5. Phagocyte cell migration is mediated by phospholipases PLD1 and PLD2;Lehman;Blood,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of phospholipase D in breast cancer;Phospholipases in Physiology and Pathology;2023

2. Phospholipase D inhibitors for targeted cancer therapy: Potentials and limitations;Phospholipases in Physiology and Pathology;2023

3. Phospholipid metabolism in cancer: Role of phospholipase D and its targeting with small-molecule inhibitors as a potential therapeutic approach for cancer;Phospholipases in Physiology and Pathology;2023

4. Systems biology approaches to unveiling the expression of phospholipases in various types of cancer—Transcriptomics and protein-protein interaction networks;Phospholipases in Physiology and Pathology;2023

5. Immunophenotype‐associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent;Cancer Medicine;2021-06-29